Cambridge Investment Research Advisors’s GAN Ltd GAN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio GAN Stock Details GAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,240	Closed	-$18K	–	3682
2025 Q1	$18K	Hold	10,240	–	–	﹤0.01%	3462
2024 Q4	$19K	Sell	10,240 -273	-3%	-$496	﹤0.01%	3422
2024 Q3	$19K	Hold	10,513	–	–	﹤0.01%	3369
2024 Q2	$16K	Hold	10,513	–	–	﹤0.01%	3275
2024 Q1	$13K	Hold	10,513	–	–	﹤0.01%	3278
2023 Q4	$17K	Hold	10,513	–	–	﹤0.01%	3148
2023 Q3	$12K	Buy	+10,513	New	+$16.5K	﹤0.01%	3105
2022 Q2	–	Sell	-11,041	Closed	-$53K	–	3115
2022 Q1	$53K	Buy	11,041 +300	+3%	+$1.93K	﹤0.01%	3071
2021 Q4	$99K	Buy	+10,741	New	+$131K	﹤0.01%	3032

Other funds holding GAN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Cambridge Investment Research Advisors's GAN Position: Q2 2025 in Review

Cambridge Investment Research Advisors sold out of GAN Ltd (GAN) in Q2 2025, closing a stake of 10,240 shares — an estimated $18K sold.

Cambridge Investment Research Advisors first reported a position in GAN in Q4 2021 and held it in 9 quarters. The position peaked at $99K in Q4 2021. 1 fund tracked by Wall St. Rank holds GAN as of Q2 2025.

Cambridge Investment Research Advisors reported no remaining GAN Ltd position as of Q2 2025 after selling out during the quarter.
Cambridge Investment Research Advisors sold 10,240 GAN Ltd shares in Q2 2025, an estimated $18K.
Cambridge Investment Research Advisors first reported a position in GAN Ltd in Q4 2021 and held it in 9 quarters.
Cambridge Investment Research Advisors's GAN Ltd position peaked at $99K in Q4 2021.
1 fund tracked by Wall St. Rank held GAN Ltd as of Q2 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.